Sort by
Refine Your Search
-
and will contribute to key modeling and simulation deliverables for drug candidates across early and late stages of clinical development, spanning multiple therapeutic modalities. The Fellows will
-
of clinical development, spanning multiple therapeutic modalities. The Fellows will support project leads at Moderna by evaluating and implementing model-informed drug development (MIDD) strategies, including
-
will have the opportunity to develop and implement independent research projects during the fellowship period. Qualifications: Doctoral degree in public health, personal health informatics, psychology
-
of Health Sciences, Northeastern University, Boston. Thakur Lab has been at the forefront in developing GPCR (cannabinoid receptors 1 and 2) allosteric modulators of the GPCR receptor as well as ligand-gated
-
opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly
-
the Department of Pharmaceutical Sciences, Bouve College of Health Sciences, Northeastern University, Boston. Thakur Lab has been at the forefront in developing GPCR (cannabinoid receptors 1 and 2) allosteric
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service
-
of Pharmaceutical Sciences, Bouve College of Health Sciences, Northeastern University, Boston. Thakur Lab has been at the forefront in developing GPCR (cannabinoid receptors 1 and 2) allosteric modulators of GPCR